Nursing care of 22 patients with complex intracranial aneurysms treated with flow-diverting stents: A retrospective study [0.03%]
使用血流导向支架治疗的22例复杂颅内动脉瘤患者的护理回顾性研究
Wenli Zhao,Huizhen Peng,Hongmei Zhang et al.
Wenli Zhao et al.
Objective: To summarize the nursing treatment of patients who underwent implantation of a blood flow diverter to treat complex intracranial aneurysms. Met...
Strategies for the diagnosis and treatment of the iliac vein compression syndrome [0.03%]
髂静脉受压综合征的诊断和治疗策略
Lin Ouyang,Xinjian Peng,Shuibin Chen
Lin Ouyang
Aim: To evaluate the diagnosis and treatment strategies for the iliac vein compression syndrome (IVCS) and the factors that affect the treatment outcome. ...
Treatment of cavernous sinus dural arteriovenous fistula using different surgical approaches: Analysis of 32 consecutive cases [0.03%]
不同手术入路治疗海绵窦硬脑膜动静脉瘘的临床分析（32例）
Bin Xu,Ziliang Wang,Weixing Bai et al.
Bin Xu et al.
Objective: Transarterial and transvenous embolization methods are considered effective and safe approaches for the treatment of cavernous sinus dural arteriovenous fistula (CSDAVF). Here., we report the angioarchitectural...
Application of abdominal aortic balloon occlusion followed by uterine artery embolization for the treatment of pernicious placenta previa complicated with placenta accreta during cesarean section [0.03%]
腹主动脉球囊阻断联合子宫动脉栓塞治疗凶险性前置胎盘合并胎盘植入行剖宫产术中的应用
Yanli Wang,Guohao Huang,Tian Jiang et al.
Yanli Wang et al.
Objective: This study aimed to investigate the clinical effects of abdominal aortic balloon occlusion followed by uterine artery embolization for the treatment of pernicious placenta previa complicated with placenta accre...
Endovascular transvenous treatment for superficial intracranial arteriovenous malformations [0.03%]
浅表性颅内动静脉畸形的血管内静脉治疗法
WeiXing Bai,YanYan He,YingKun He et al.
WeiXing Bai et al.
Objective: The objective of this study was to evaluate the feasibility and outcomes of transvenous endovascular embolization (TVE) for superficial intracranial arteriovenous malformations (AVMs). ...
Yang Xu,Xuemei Wang,Yongde Cheng
Yang Xu
Intervention nursing emerged in China in the 1980s. It has been developing rapidly since then, along with interventional radiology, and has become an indispensable professional discipline in clinical nursing. In this paper, the author focus...
Special considerations in the management of lower GI bleed by interventional radiology [0.03%]
介入放射学在下消化道出血管理中的特殊考虑因素
Shihong Li,Brendan Oshea,Shiliang Sun
Shihong Li
Despite the rapid development of diagnostic and therapeutic modalities and techniques to manage LGIB patients from interventional radiology's standpoint, a successful localization of the bleeding site that leads to an effective embolotherap...
Safety and efficacy of hepatic arterial infusion chemotherapy with raltitrexed and oxaliplatin post-transarterial chemoembolization for unresectable hepatocellular carcinoma [0.03%]
经动脉化疗栓塞术后使用瑞替普雷和奥沙利铂肝动脉灌注化疗治疗不可切除的肝细胞癌的安全性和有效性研究
Baojiang Liu,Xu Zhu,Song Gao et al.
Baojiang Liu et al.
Objective: To investigate the safety, efficacy, and prognostic factors of hepatic arterial infusion chemotherapy (HAIC) with raltitrexed and oxaliplatin post-transarterial chemoembolization (TACE) for unresectable hepatoc...
Safety and efficacy of microwave ablation for periductal hepatocellular carcinoma with intraductal cooling of the central bile ducts through a percutaneous transhepatic cholangial drainage tube [0.03%]
经皮肝胆管引流管对肝内胆管中央区冷却对肝内胆管癌微波消融的安全性和有效性研究
Naijian Ge,Jian Huang,Zhiyong Shi et al.
Naijian Ge et al.
Background and aims: Biliary thermal injury caused by microwave ablation (MWA) for a hepatocellular carcinoma (HCC) close to the central bile ducts always results in severe complications and leads to mortality. Some studi...
Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma [0.03%]
索拉非尼联合奥沙利铂肝动脉灌注化疗与单用索拉非尼治疗晚期肝细胞癌的对比研究
Yang Zhao,JiaYing Lai,RunBin Liang et al.
Yang Zhao et al.
Objective: To compare the efficacy of sorafenib plus hepatic arterial infusion chemotherapy (HAIC) with oxaliplatin to that of sorafenib alone in patients with advanced hepatocellular carcinoma (HCC). ...